• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮介入封堵术治疗小儿动脉导管未闭所致心肌损伤及炎症反应。

Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus.

机构信息

Department of Cardiovascular Surgery and Cardiac Disease Center, Union Hospital, Fujian Medical University, Fuzhou, 350001, People's Republic of China.

Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, People's Republic of China.

出版信息

BMC Cardiovasc Disord. 2022 May 18;22(1):228. doi: 10.1186/s12872-022-02666-x.

DOI:10.1186/s12872-022-02666-x
PMID:35585489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9118593/
Abstract

BACKGROUND

The percutaneous device closure of patent ductus arteriosus (PDA) is widely used in clinical practice, however full data on the changes in myocardial injury and systemic inflammatory markers' levels after PDA in children are not fully reported.

METHODS

We have conducted a retrospective analysis of the medical records of 385 pediatric patients in our hospital from January 2017 to December 2019. The patients were distributed into five groups. The first four (A, B, C and D) included patients divided by the type of the surgical closure methods, namely ligation, clamping, ligation-combined suturing and ligation-combined clamping, respectively. The fifth group E comprised of percutaneous device PDA patients. All recorded medical and trial data from the five groups were statistically studied.

RESULTS

No serious complications in the patients regardless of the classification group were reported. Our results suggested that there were no considerable differences between the groups at the baseline (with all P > 0.05). Group E demonstrated a significantly smaller operative time (42.39 ± 3.88, min) and length of hospital stay (LOS) (4.49 ± 0.50, day), less intraoperative blood loss (7.12 ± 2.09, ml) while on the other hand, a higher total hospital cost (24,001.35 ± 1152.80, RMB) than the other four groups (with all P < 0.001). Interestingly, the comparison of the inflammatory factors such as white blood cells (WBC) count, C-reactive protein (CRP), procalcitonin (PCT) and interleukin-6 (IL-6), as well as the myocardial injury markers (CKMB and troponin I) did not show a significant increase (P > 0.05) among the four groups. On the contrary, when the aforementioned factors and markers of all the surgical groups were compared to those in group E, we observed significantly higher speed and magnitude of changes in group E than those in groups A, B, C, and D (with all P < 0.001).

CONCLUSION

Although the percutaneous device closure of PDA is more comforting and drives fast recuperation in comparison to conventional surgery, it provokes myocardial injury and overall inflammation. Timely substantial and aggressive intervention measures such as the use of antibiotics before operation and active glucocorticoids to suppress inflammation and nourish the myocardium need be applied if the myocardial and inflammatory markers are eminent.

摘要

背景

动脉导管未闭(PDA)的经皮器械封堵术在临床实践中得到广泛应用,然而,关于儿童 PDA 后心肌损伤和全身炎症标志物水平变化的完整数据尚未完全报道。

方法

我们对 2017 年 1 月至 2019 年 12 月我院 385 例儿科患者的病历进行了回顾性分析。患者分为五组。前四组(A、B、C 和 D)分别为结扎、夹闭、结扎缝合和结扎夹闭的手术闭合方法,第五组 E 为经皮器械 PDA 患者。对五组所有记录的医学和试验数据进行了统计学研究。

结果

无论分类组如何,患者均未报告严重并发症。我们的结果表明,各组在基线时无明显差异(均 P>0.05)。E 组手术时间(42.39±3.88 分钟)和住院时间(LOS)(4.49±0.50 天)明显缩短,术中出血量(7.12±2.09ml)减少,另一方面,总住院费用(24001.35±1152.80 元)高于其他四组(均 P<0.001)。有趣的是,与其他四组相比,白细胞(WBC)计数、C 反应蛋白(CRP)、降钙素原(PCT)和白细胞介素-6(IL-6)等炎症因子以及肌酸激酶同工酶(CKMB)和肌钙蛋白 I 等心肌损伤标志物的比较并未显示出明显增加(P>0.05)。相反,当将上述所有手术组的因素和标志物与 E 组进行比较时,我们观察到 E 组的变化速度和幅度明显高于 A、B、C 和 D 组(均 P<0.001)。

结论

与传统手术相比,经皮器械封堵 PDA 更为舒适,恢复更快,但会引起心肌损伤和全身炎症。如果心肌和炎症标志物明显,需要及时采取抗生素术前应用和积极糖皮质激素抑制炎症和营养心肌等大量积极的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/cc3c8ec886f3/12872_2022_2666_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/37112e4c4bdc/12872_2022_2666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/5573d008c45b/12872_2022_2666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/af4b50e61194/12872_2022_2666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/9263a9aae371/12872_2022_2666_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/cc3c8ec886f3/12872_2022_2666_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/37112e4c4bdc/12872_2022_2666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/5573d008c45b/12872_2022_2666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/af4b50e61194/12872_2022_2666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/9263a9aae371/12872_2022_2666_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba0/9118593/cc3c8ec886f3/12872_2022_2666_Fig5_HTML.jpg

相似文献

1
Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus.经皮介入封堵术治疗小儿动脉导管未闭所致心肌损伤及炎症反应。
BMC Cardiovasc Disord. 2022 May 18;22(1):228. doi: 10.1186/s12872-022-02666-x.
2
Surgical Versus Percutaneous Closure of PDA in Preterm Infants: Procedural Charges and Outcomes.经胸与经皮动脉导管未闭封堵术治疗早产儿的比较:操作费用与结局。
J Surg Res. 2019 Nov;243:41-46. doi: 10.1016/j.jss.2019.04.069. Epub 2019 May 30.
3
Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?极低体重早产儿动脉导管未闭的手术结扎与经皮封堵:经皮封堵方法的真正益处有哪些?
Pediatr Cardiol. 2018 Feb;39(2):398-410. doi: 10.1007/s00246-017-1768-5. Epub 2017 Nov 8.
4
Is transcatheter closure superior to surgical ligation of patent ductus arteriosus among Nigerian Children?在尼日利亚儿童中,经导管封堵术治疗动脉导管未闭是否优于外科结扎术?
Afr J Paediatr Surg. 2018 Apr-Jun;15(2):100-103. doi: 10.4103/ajps.AJPS_53_17.
5
Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications.极早产儿经皮动脉导管未闭(PDA)封堵术:可行性与并发症
J Am Heart Assoc. 2016 Feb 12;5(2):e002923. doi: 10.1161/JAHA.115.002923.
6
Percutaneous closure of a large patent ductus arteriosus in a preterm newborn weighing 1400 g without using arterial sheath: an innovative technique.在一名体重1400克的早产新生儿中不使用动脉鞘进行经皮闭合大型动脉导管未闭:一种创新技术。
Cardiol Young. 2018 Mar;28(3):494-497. doi: 10.1017/S1047951117002475. Epub 2017 Dec 13.
7
Patent Ductus Arteriosus closure in preterms less than 2kg: Surgery versus transcatheter.早产儿体重不足 2 公斤时动脉导管未闭的封堵:外科手术与经导管治疗。
Int J Cardiol. 2018 Jan 1;250:110-115. doi: 10.1016/j.ijcard.2017.10.020. Epub 2017 Oct 6.
8
Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.使用Amplatzer动脉导管封堵器额外尺寸-ADOIIAS对32例早产儿血流动力学显著的动脉导管未闭进行经导管封堵术。
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):612-617. doi: 10.1002/ccd.27091. Epub 2017 May 4.
9
Comparison of effectiveness and cost of patent ductus arteriosus device occlusion versus surgical ligation of patent ductus arteriosus.动脉导管未闭封堵器封堵与动脉导管未闭手术结扎的有效性及成本比较。
Pak J Med Sci. 2016 Jul-Aug;32(4):974-7. doi: 10.12669/pjms.324.10048.
10
Surgical Closure of Patent Ductus Arteriosus in Premature Neonates Weighing Less Than 1,000 grams: Contemporary Outcomes.体重小于1000克早产儿动脉导管未闭的手术闭合:当代疗效
World J Pediatr Congenit Heart Surg. 2018 Jul;9(4):419-423. doi: 10.1177/2150135118766454.

本文引用的文献

1
Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams.体重低于1500克婴儿动脉导管未闭的经导管封堵术
Front Pediatr. 2020 Sep 22;8:558256. doi: 10.3389/fped.2020.558256. eCollection 2020.
2
Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients.小儿患者经胸封堵室间隔缺损后炎症标志物水平的变化
J Cardiothorac Surg. 2019 Apr 8;14(1):70. doi: 10.1186/s13019-019-0900-4.
3
The Short and Midterm Follow-Up of Transthoracic Device Closure of Perimembranous Ventricular Septal Defect in Adults.
成人经胸封堵膜周部室间隔缺损的短期和中期随访
Heart Surg Forum. 2018 Jun 14;21(4):E242-E246. doi: 10.1532/hsf.1932.
4
Postoperative kinetics of common inflammatory biomarkers after congenital heart defect procedures with extracorporeal circulation in children.儿童体外循环先天性心脏病手术后常见炎症生物标志物的术后动力学。
Kardiol Pol. 2018;76(6):968-973. doi: 10.5603/KP.a2018.0038. Epub 2018 Feb 5.
5
Diagnostic Value of Procalcitonin on Early Postoperative Infection After Pediatric Cardiac Surgery.降钙素原对小儿心脏手术后早期感染的诊断价值
Pediatr Crit Care Med. 2017 May;18(5):420-428. doi: 10.1097/PCC.0000000000001118.
6
Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles.多种生物标志物对成人先天性心脏病心血管死亡的预后价值:单心室/双心室生理及形态学上的体循环右心室/左心室的比较
Heart Vessels. 2016 Nov;31(11):1834-1847. doi: 10.1007/s00380-016-0807-0. Epub 2016 Feb 8.
7
Risk factors for systemic inflammatory response after congenital cardiac surgery.先天性心脏手术后全身炎症反应的危险因素。
J Card Surg. 2015 Jan;30(1):92-6. doi: 10.1111/jocs.12465. Epub 2014 Nov 10.
8
Kinetics of C-reactive protein in children with congenital heart diseases in the early period after cardiosurgical treatment with extracorporeal circulation.体外循环心外科手术后早期先天性心脏病患儿 C 反应蛋白的动力学变化。
Adv Med Sci. 2014 Mar;59(1):19-22. doi: 10.1016/j.advms.2013.06.001. Epub 2014 Mar 15.
9
A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD).经导管装置封堵室间隔缺损(VSD)的疗效与安全性的系统评价。
J Interv Cardiol. 2014 Jun;27(3):260-72. doi: 10.1111/joic.12121. Epub 2014 Apr 29.
10
Percutaneous closure of patent ductus arteriosus in interrupted inferior caval vein through femoral vein approach.经股静脉途径经皮闭合下腔静脉中断处的动脉导管未闭。
Ann Pediatr Cardiol. 2014 Jan;7(1):55-7. doi: 10.4103/0974-2069.126560.